Cancer Prevention Institute of California, Fremont, CA 94538, USA.
J Natl Cancer Inst. 2013 Aug 7;105(15):1096-110. doi: 10.1093/jnci/djt157. Epub 2013 Jul 22.
National cancer incidence trends are presented for eight Asian American groups: Asian Indians/Pakistanis, Chinese, Filipinos, Japanese, Kampucheans, Koreans, Laotians, and Vietnamese.
Cancer incidence data from 1990 through 2008 were obtained from 13 Surveillance, Epidemiology, End Results (SEER) registries. Incidence rates from 1990 through 2008 and average percentage change were computed using SEER*Stat and Joinpoint software. The annual percentage change (APC) in incidence rates was estimated with 95% confidence intervals (95% CIs) calculated for both the rate and APC estimates. Rates for non-Hispanic whites are presented for comparison.
Prostate cancer was the most common malignancy among most groups, followed by lung, colorectal, liver, and stomach cancers. Breast cancer was generally the most common cancer in women, followed by colorectal and lung cancers; liver, cervix, thyroid, and stomach cancers also ranked highly. Among men, increasing trends were observed for prostate (Asian Indians and Pakistanis: APC 1990-2003 = 2.2, 95% CI = 0.3 to 4.1; Filipinos: APC 1990-1994 = 19.0, 95% CI = 4.5 to 35.4; Koreans: APC 1990-2008 = 2.9, 95% CI = 1.8 to 4.0), colorectal (Koreans: APC 1990-2008 = 2.2, 95% CI = 0.9 to 3.5), and liver cancers (Filipinos: APC 1990-2008 = 1.6, 95% CI = 0.4 to 2.7; Koreans: APC 1990-2006 = 2.1, 95% CI = 0.4 to 3.7; Vietnamese: APC 1990-2008 = 1.6, 95% CI = 0.3 to 2.8), whereas lung and stomach cancers generally remained stable or decreased. Among women, increases were observed for uterine cancer (Asian Indians: APC 1990-2008 = 3.0, 95% CI = 0.3 to 5.8; Chinese: APC 2004-2008 = 7.0, 95% CI = 1.4 to 12.9; Filipina: APC 1990-2008 = 3.0, 95% CI = 2.4 to 3.7; Japanese: APC 1990-2008 = 1.1, 95% CI = 0.1 to 2.0), colorectal cancer (Koreans: APC 1990-2008 = 2.8, 95% CI = 1.7 to 3.9; Laotians: APC: 1990-2008 = 5.9, 95% CI = 4.0 to 7.7), lung cancer (Filipinas: APC 1990-2008 = 2.1, 95% CI = 1.4 to 2.8; Koreans: APC 1990-2008 = 2.1, 95% CI = 0.6 to 3.6), thyroid cancer (Filipinas: APC 1990-2008 = 2.5, 95% CI = 1.7 to 3.3), and breast cancer in most groups (APC 1990-2008 from 1.2 among Vietnamese and Chinese to 4.7 among Koreans). Decreases were observed for stomach (Chinese and Japanese), colorectal (Chinese), and cervical cancers (Laotians and Vietnamese).
These data fill a critical knowledge gap concerning the cancer experience of Asian American groups and highlight where increased preventive, screening, and surveillance efforts are needed-in particular, lung cancer among Filipina and Korean women and Asian Indian/Pakistani men, breast cancer among all women, and liver cancer among Vietnamese, Laotian, and Kampuchean women and Filipino, Kampuchean, and Vietnamese men.
呈现了 8 个亚裔美国人族群的癌症发病趋势:印度裔/巴基斯坦裔、中国人、菲律宾人、日本人、高棉人、韩国人、老挝人和越南人。
从 13 个监测、流行病学和结局(SEER)登记处获取了 1990 年至 2008 年的癌症发病数据。使用 SEER*Stat 和 Joinpoint 软件计算了 1990 年至 2008 年的发病率和平均百分比变化,并估算了年度百分比变化(APC)的 95%置信区间(95%CI)。为了进行比较,还呈现了非西班牙裔白种人的发病率数据。
前列腺癌是大多数族群中最常见的恶性肿瘤,其次是肺癌、结直肠癌、肝癌和胃癌。乳腺癌通常是女性中最常见的癌症,其次是结直肠癌和肺癌;肝癌、宫颈癌、甲状腺癌和胃癌的发病率也较高。在男性中,前列腺癌(印度裔/巴基斯坦裔:1990-2003 年 APC=2.2,95%CI=0.3 至 4.1;菲律宾人:1990-1994 年 APC=19.0,95%CI=4.5 至 35.4;韩国人:1990-2008 年 APC=2.9,95%CI=1.8 至 4.0)、结直肠癌(韩国人:1990-2008 年 APC=2.2,95%CI=0.9 至 3.5)和肝癌(菲律宾人:1990-2008 年 APC=1.6,95%CI=0.4 至 2.7;韩国人:1990-2006 年 APC=2.1,95%CI=0.4 至 3.7;越南人:1990-2008 年 APC=1.6,95%CI=0.3 至 2.8)呈上升趋势,而肺癌和胃癌的发病率则相对稳定或下降。在女性中,子宫癌(印度裔:1990-2008 年 APC=3.0,95%CI=0.3 至 5.8;中国人:2004-2008 年 APC=7.0,95%CI=1.4 至 12.9;菲律宾人:1990-2008 年 APC=3.0,95%CI=2.4 至 3.7;日本人:1990-2008 年 APC=1.1,95%CI=0.1 至 2.0)、结直肠癌(韩国人:1990-2008 年 APC=2.8,95%CI=1.7 至 3.9;老挝人:APC:1990-2008=5.9,95%CI=4.0 至 7.7)、肺癌(菲律宾人:1990-2008 年 APC=2.1,95%CI=1.4 至 2.8;韩国人:1990-2008 年 APC=2.1,95%CI=0.6 至 3.6)、甲状腺癌(菲律宾人:1990-2008 年 APC=2.5,95%CI=1.7 至 3.3)和大多数族群的乳腺癌(APC 1990-2008 从越南人和中国人的 1.2 到韩国人的 4.7)发病率上升。胃癌(中国人和日本人)、结直肠癌(中国人)和宫颈癌(老挝人和越南人)的发病率则下降。
这些数据填补了有关亚裔美国人族群癌症发病情况的重要知识空白,并突出了需要加强预防、筛查和监测工作的领域,特别是菲律宾和韩国女性的肺癌、所有女性的乳腺癌以及越南、老挝和高棉女性和菲律宾、高棉和越南男性的肝癌。